205 related articles for article (PubMed ID: 23851259)
1. FG7142, yohimbine, and βCCE produce anxiogenic-like effects in the elevated plus-maze but do not affect brainstem activated hippocampal theta.
Yeung M; Lu L; Hughes AM; Treit D; Dickson CT
Neuropharmacology; 2013 Dec; 75():47-52. PubMed ID: 23851259
[TBL] [Abstract][Full Text] [Related]
2. A critical test of the hippocampal theta model of anxiolytic drug action.
Yeung M; Treit D; Dickson CT
Neuropharmacology; 2012 Jan; 62(1):155-60. PubMed ID: 21723303
[TBL] [Abstract][Full Text] [Related]
3. Ventral hippocampal histamine increases the frequency of evoked theta rhythm but produces anxiolytic-like effects in the elevated plus maze.
Yeung M; Treit D; Dickson CT
Neuropharmacology; 2016 Jul; 106():146-55. PubMed ID: 26400409
[TBL] [Abstract][Full Text] [Related]
4. Intrahippocampal infusion of the Ih blocker ZD7288 slows evoked theta rhythm and produces anxiolytic-like effects in the elevated plus maze.
Yeung M; Dickson CT; Treit D
Hippocampus; 2013 Apr; 23(4):278-86. PubMed ID: 23280856
[TBL] [Abstract][Full Text] [Related]
5. GABA-A receptor modulators alter emotionality and hippocampal theta rhythm in an animal model of long-lasting anxiety.
Hoeller AA; Duzzioni M; Duarte FS; Leme LR; Costa AP; Santos EC; de Pieri CH; dos Santos AA; Naime AA; Farina M; de Lima TC
Brain Res; 2013 Sep; 1532():21-31. PubMed ID: 23911836
[TBL] [Abstract][Full Text] [Related]
6. Ethopharmacological analysis of the unstable elevated exposed plus maze, a novel model of extreme anxiety: predictive validity and sensitivity to anxiogenic agents.
Jones N; Duxon MS; King SM
Psychopharmacology (Berl); 2002 May; 161(3):314-23. PubMed ID: 12021835
[TBL] [Abstract][Full Text] [Related]
7. Anxiolytic- and antidepressant-like properties of ketamine in behavioral and neurophysiological animal models.
Engin E; Treit D; Dickson CT
Neuroscience; 2009 Jun; 161(2):359-69. PubMed ID: 19321151
[TBL] [Abstract][Full Text] [Related]
8. Behavioral anxiolysis without reduction of hippocampal theta frequency after histamine application in the lateral septum of rats.
Chee SS; Menard JL; Dringenberg HC
Hippocampus; 2014 Jun; 24(6):615-27. PubMed ID: 24436118
[TBL] [Abstract][Full Text] [Related]
9. Anxiolytic profile of pregabalin on elicited hippocampal theta oscillation.
Siok CJ; Taylor CP; Hajós M
Neuropharmacology; 2009 Feb; 56(2):379-85. PubMed ID: 18930748
[TBL] [Abstract][Full Text] [Related]
10. Similar anxiolytic-like effects following intra-amygdala infusions of benzodiazepine receptor agonist and antagonist: evidence for the release of an endogenous benzodiazepine inverse agonist in mice exposed to elevated plus-maze test.
Barbalho CA; Nunes-de-Souza RL; Canto-de-Souza A
Brain Res; 2009 Apr; 1267():65-76. PubMed ID: 19268657
[TBL] [Abstract][Full Text] [Related]
11. Bidirectional effects of benzodiazepine binding site ligands in the elevated plus-maze: differential antagonism by flumazenil and beta-CCt.
Savić MM; Obradović DI; Ugresić ND; Cook JM; Yin W; Bokonjić DR
Pharmacol Biochem Behav; 2004 Oct; 79(2):279-90. PubMed ID: 15501303
[TBL] [Abstract][Full Text] [Related]
12. Role of ventral hippocampal GABA(A) and NMDA receptors in the anxiolytic effect of carbamazepine in rats using the elevated plus maze test.
Rezvanfard M; Zarrindast MR; Bina P
Pharmacology; 2009; 84(6):356-66. PubMed ID: 19907194
[TBL] [Abstract][Full Text] [Related]
13. Anxiolytic and antidepressant effects of intracerebroventricularly administered somatostatin: behavioral and neurophysiological evidence.
Engin E; Stellbrink J; Treit D; Dickson CT
Neuroscience; 2008 Dec; 157(3):666-76. PubMed ID: 18940236
[TBL] [Abstract][Full Text] [Related]
14. The gerbil elevated plus-maze I: behavioral characterization and pharmacological validation.
Varty GB; Morgan CA; Cohen-Williams ME; Coffin VL; Carey GJ
Neuropsychopharmacology; 2002 Sep; 27(3):357-70. PubMed ID: 12225693
[TBL] [Abstract][Full Text] [Related]
15. The effects of moclobemide on the yohimbine-induced anxiogenic action in the elevated plus-maze.
Eroğlu L; Güven O
Pharmacol Res; 1998 Feb; 37(2):137-43. PubMed ID: 9572069
[TBL] [Abstract][Full Text] [Related]
16. The lateral septum as a regulator of hippocampal theta oscillations and defensive behavior in rats.
Chee SS; Menard JL; Dringenberg HC
J Neurophysiol; 2015 Mar; 113(6):1831-41. PubMed ID: 25589592
[TBL] [Abstract][Full Text] [Related]
17. Is hippocampal theta frequency related to individual and sex differences in anxiety-like behaviour? An analysis in male and female Long-Evans rats.
Ou C; Dringenberg HC; Soutar CN
Behav Brain Res; 2019 May; 364():366-373. PubMed ID: 30753872
[TBL] [Abstract][Full Text] [Related]
18. Modulatory effects of the basolateral amygdala α2-adrenoceptors on nicotine-induced anxiogenic-like behaviours of rats in the elevated plus maze.
Bashiri H; Rezayof A; Sahebgharani M; Tavangar SM; Zarrindast MR
Neuropharmacology; 2016 Jun; 105():478-486. PubMed ID: 26878830
[TBL] [Abstract][Full Text] [Related]
19. Reversal of benzodiazepine inverse agonist FG 7142-induced anxiety syndrome by neurosteroids in mice.
Reddy DS; Kulkarni SK
Methods Find Exp Clin Pharmacol; 1997 Dec; 19(10):665-81. PubMed ID: 9542718
[TBL] [Abstract][Full Text] [Related]
20. Serotonergic systems associated with arousal and vigilance behaviors following administration of anxiogenic drugs.
Abrams JK; Johnson PL; Hay-Schmidt A; Mikkelsen JD; Shekhar A; Lowry CA
Neuroscience; 2005; 133(4):983-97. PubMed ID: 15916857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
